A5021089521- Pharmaceutical Practices and Patient Outcomes
- Medication Adherence and Compliance
- Health Literacy and Information Accessibility
- COVID-19 and Mental Health
- Chronic Disease Management Strategies
- Dementia and Cognitive Impairment Research
- Pharmaceutical studies and practices
- Mobile Health and mHealth Applications
- Health disparities and outcomes
- Digital Mental Health Interventions
- Mental Health Treatment and Access
- LGBTQ Health, Identity, and Policy
- Vaccine Coverage and Hesitancy
- Cancer Genomics and Diagnostics
- Patient-Provider Communication in Healthcare
- Reproductive Health and Technologies
- Lung Cancer Treatments and Mutations
- Misinformation and Its Impacts
- Cardiac Health and Mental Health
- Opioid Use Disorder Treatment
- Diabetes Management and Education
- Health Systems, Economic Evaluations, Quality of Life
- Pharmacovigilance and Adverse Drug Reactions
- Reproductive Biology and Fertility
- Psychological Well-being and Life Satisfaction
Northwestern University
2016-2025
Institute on Aging
2023
Amgen (United States)
2017-2018
University of Arizona
2005
The evolving outbreak of coronavirus disease 2019 (COVID-19) is requiring social distancing and other measures to protect public health. However, messaging has been inconsistent unclear.
The US outbreak of coronavirus disease 2019 (COVID-19) accelerated rapidly over a short time to become public health crisis. To assess how high-risk adults' COVID-19 knowledge, beliefs, behaviors, and sense preparedness changed from the onset (March 13–20, 2020) acceleration phase 27–April 7, 2020). Longitudinal, two-wave telephone survey. 588 predominately older adults with ≥ 1 chronic condition recruited 4 active, federally funded studies in Chicago. Self-reported knowledge symptoms...
Individuals with mild cognitive impairment (MCI) or dementia work family caregivers and clinicians to manage multidrug regimens; however, problems medication management are common contribute avoidable hospitalizations among individuals dementia. We sought describe the initiation of these triadic clinical encounters identify opportunities enhance them. conducted semi-structured qualitative interviews MCI dementia, their primary care clinicians. Clinicians were not required provide for...
Pharmaceutical risk minimization programs involve interventions designed to support safe and appropriate use of medicines. Currently, information regarding the evaluation these is not publicly reported in a standardized transparent manner. To address this gap, we developed piloted quality reporting checklist entitled Reporting recommendations Intended for pharmaceutical Minimization Evaluation Studies (RIMES). Checklist development was guided by three sources: (1) theoretical framework...
To examine the prevalence of mental health symptoms during first surge COVID-19 in USA, and their associations with COVID-19-related emotional distress, self-management healthcare utilisation. Cross-sectional analysis wave 3 (1-22 May 2020) survey data from ongoing Chicago Comorbidities (C3) study. Seven academic community centres Chicago, Illinois. 565 adults aged 23-88 one or more chronic conditions completing at least prior C3 study wave. Clinically relevant anxiety depressive as measured...
This study examined the relationship between scores on “speeded” cognitive and academic tests need for accommodation of extended test time normally achieving students (NA) with learning disabilities (LD). Often, in postsecondary settings decision to provide is based largely diagnostic student's LD documentation. Therefore, primary purpose this was evaluate specific time. A secondary investigate relationships predictive ability five speeded tests, three cluster scores, two measures timed...
Abstract Objectives Despite increased focus on opioid prescribing, little is known about the influence of prescription medication information given to patients in emergency department (ED). The study objective was evaluate effect an Electronic Medication Complete Communication (EMC 2 ) Opioid Strategy patients’ safe use opioids and knowledge opioids. Methods This a three‐arm prospective, randomized controlled pragmatic trial with randomization occurring at physician level. Consecutive...
With changing cognitive abilities, individuals with mild impairment (MCI) and dementia face challenges in successfully managing multidrug regimens. We sought to understand how MCI or their family caregivers manage regimens better patient-to-caregiver transitions medication management responsibilities.
Abstract Background Poor‐quality patient drug information has been identified as a major cause of preventable medication errors in the United States. The US Food and Drug Administration (FDA) authority to require marketing authorization holders medicinal products implement risk evaluation mitigation strategies (REMS) ensure that benefits or biological product outweigh its risks. Aside from guides, no research conducted assess quality patient‐targeted REMS materials, including whether, what...
Health systems and insurers alike are increasingly interested in leveraging mHealth (mobile health) tools to support patient health-related behaviors including medication adherence. However, these not widely used by older patients. This study explores preferences for functionality a smartphone application (app) that supports self-management among adults with multiple chronic conditions. We conducted six discussion groups Chicago, Miami, Denver (N = 46). English-speaking (55 older) who owned...
In a large academic medical center, processes for ordering and receiving biomarker testing to inform cancer treatment in non–small cell lung varied by whether tests were conducted internally or externally. Lack of standardization processes, despite the availability electronic health record solutions, contributes clinician burden may increase risk delays receipt results; therefore, efforts streamline benefit systems.
Background: At the onset of pandemic, there was poor public awareness and inaction in response to COVID-19; it is less known whether this translated subsequent infections. Objectives: To explore adults who perceived COVID-19 as a threat were not taking early actions more likely become infected over following year. Research Design: Survey data from ongoing (COVID-19 & Chronic Conditions (C3) anonymized for review) cohort study. Participants: Six hundred forty-two with mean age 63 ≥1...
Abstract Objective We sought to characterize caregiver medication assistance for older adults with multiple chronic conditions. Design Semi‐structured qualitative interviews. Setting Community and academic‐affiliated primary care practices. Participants A total of 25 caregivers participating in an ongoing cohort study ≥3 Measurements semi‐structured interview guide, informed by the Medication Self‐Management model, aimed understand health‐related medication‐specific provided. Results Three...
Introduction The lack of definitive means to prevent or treat cognitive impairment dementia is driving intense efforts identify causal mechanisms. Recent evidence suggests clinically meaningful declines in cognition might present as early middle age. Studying changes adulthood could elucidate modifiable factors affecting later and health outcomes, yet few ageing studies include this age group. purpose the MidCog study begin investigations less-studied potentially midlife determinants life...
To investigate well-being, lifestyle behaviors, self-management capacity and healthcare utilization among adults with chronic conditions at the outbreak of COVID-19 pandemic. Data was collected from two interviewer-administered telephone surveys conducted between March 27 – May 22, 2020. Participants were patients Chicago-area clinics. Self-report validated measures used for study-related outcomes. A total 553 participants (age range 23–88) completed data collection both timepoints. One in...